ALPHACORE PHARMA, LLC

Basic Information

ALPHACORE PHARMA, LLC
2900 Huron Parkway, Suite 5
ANN ARBOR, MI, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 801351896
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion

    Amount: $1,254,300.00

    DESCRIPTION (provided by applicant): The hallmark of atherosclerosis is the accumulation of cholesterol in arteries, resulting in plaque which can lead to a heart attack (myocardial infarction (MI)) ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. The Use of LCAT Infusion to Treat Acute Coronary Syndromes

    Amount: $240,129.00

    DESCRIPTION (provided by applicant): Coronary heart disease, the most prevalent manifestation of atherosclerosis, remains the single largest killer of American men and women. The hallmark of vascula ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government